Dehydroepiandrosterone prevents age-associated alterations, increasing insulin sensitivity

Journal of Nutritional Biochemistry

Volumn 19, Issue 12, 2008, Pages 809-818

  Sánchez, Juana ^a   Pérez Heredia, Fátima ^b   Priego, Teresa ^a   Portillo, Maria P ^c   Zamora, Salvador ^b   Garaulet, Marta ^b   Palou, Andreu ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Adiponectin; DHEA; Insulin resistance; Leptin; Resistin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; INSULIN; LEPTIN; MESSENGER RNA; PRASTERONE; RESISTIN;

ADIPOSE TISSUE; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID DIET; LIPID STORAGE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RAT; SENESCENCE; SPRAGUE DAWLEY RAT; THERAPY EFFECT;

ADIPOCYTES; ADIPONECTIN; AGING; ANIMALS; APPETITE; BODY WEIGHT; DEHYDROEPIANDROSTERONE; ENERGY INTAKE; FEMALE; INSULIN; LEPTIN; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RESISTIN; RNA, MESSENGER; RNA, RIBOSOMAL, 18S;

RATTUS;

EID: 55549137715     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2007.10.005     Document Type: Article

References (67)

1. Van Gaal L.F., Mertens I.L., and De Block C.E. Mechanisms linking obesity with cardiovascular disease. Nature 444 (2006) 875-880
2. Kahn S.E., Hull R.L., and Utzschneider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444 (2006) 840-846
3. Rosen E.D., and Spiegelman B.M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444 (2006) 847-853
4. Maffei M., Halaas J., Ravussin E., Pratley R., Lee G., Zhang Y., et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1 (1995) 1155-1161
5. Ostlund Jr. R., Yang J., Klein S., and Gingerich R. Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab 81 (1996) 3909-3913
6. Campfield L., Smith F., Guisez Y., Devos R., and Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269 (1995) 546-549
7. Palou A., Serra F., Bonet M., and Pico C. Obesity: molecular bases of a multifactorial problem. Eur J Nutr 39 (2000) 127-144
8. Oliver P., Ribot J., Rodriguez A.M., Sanchez J., Pico C., and Palou A. Resistin as a putative modulator of insulin action in the daily feeding/fasting rhythm. Pflugers Arch 452 (2006) 260-267
9. Hu E., Liang P., and Spiegelman B.M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271 (1996) 10697-10703
10. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86 (2001) 1930-1935
11. Yang W.S., Lee W.J., Funahashi T., Tanaka S., Matsuzawa Y., Chao C.L., et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86 (2001) 3815-3819
12. Milan G., Granzotto M., Scarda A., Calcagno A., Pagano C., Federspil G., et al. Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obes Res 10 (2002) 1095-1103
13. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., et al. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
14. Banerjee R.R., Rangwala S.M., Shapiro J.S., Rich A.S., Rhoades B., Qi Y., et al. Regulation of fasted blood glucose by resistin. Science 303 (2004) 1195-1198
15. Kim K.H., Zhao L., Moon Y., Kang C., and Sul H.S. Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity. Proc Natl Acad Sci U S A 101 (2004) 6780-6785
16. Felipe F., Bonet M.L., Ribot J., and Palou A. Modulation of resistin expression by retinoic acid and vitamin A status. Diabetes 53 (2004) 882-889
17. Orentreich N., Brind J.L., Vogelman J.H., Andres R., and Baldwin H. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab 75 (1992) 1002-1004
18. Orentreich N., Brind J.L., Rizer R.L., and Vogelman J.H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59 (1984) 551-555
19. Nestler J.E., Clore J.N., and Blackard W.G. Dehydroepiandrosterone: the "missing link" between hyperinsulinemia and atherosclerosis?. Faseb J 6 (1992) 3073-3075
20. Coleman D.L., Leiter E.H., and Schwizer R.W. Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes 31 (1982) 830-833
21. Berdanier C.D., Parente Jr. J.A., and McIntosh M.K. Is dehydroepiandrosterone an antiobesity agent?. Faseb J 7 (1993) 414-419
22. Tchernof A., and Labrie F. Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies. Eur J Endocrinol 151 (2004) 1-14
23. Cleary M.P., Shepherd A., and Jenks B. Effect of dehydroepiandrosterone on growth in lean and obese Zucker rats. J Nutr 114 (1984) 1242-1251
24. Hansen P.A., Han D.H., Nolte L.A., Chen M., and Holloszy J.O. DHEA protects against visceral obesity and muscle insulin resistance in rats fed a high-fat diet. Am J Physiol 273 (1997) R1704-R1708
25. Mohan P.F., Ihnen J.S., Levin B.E., and Cleary M.P. Effects of dehydroepiandrosterone treatment in rats with diet-induced obesity. J Nutr 120 (1990) 1103-1114
26. Richards R.J., Porter J.R., and Svec F. Serum leptin, lipids, free fatty acids, and fat pads in long-term dehydroepiandrosterone-treated Zucker rats. Proc Soc Exp Biol Med 223 (2000) 258-262
27. Cleary M.P., and Zisk J.F. Anti-obesity effect of two different levels of dehydroepiandrosterone in lean and obese middle-aged female Zucker rats. Int J Obes 10 (1986) 193-204
28. Schwartz A.G., and Cleary M.P. The effect of dehydroepiandrosterone on body weight gain. J Nutr 117 (1987) 406-407
29. de Heredia F.P., Cerezo D., Zamora S., and Garaulet M. Effect of dehydroepiandrosterone on protein and fat digestibility, body protein and muscular composition in high-fat-diet-fed old rats. Br J Nutr 97 (2007) 464-470
30. Tagliaferro A.R., Davis J.R., Truchon S., and Van Hamont N. Effects of dehydroepiandrosterone acetate on metabolism, body weight and composition of male and female rats. J Nutr 116 (1986) 1977-1983
31. Kajita K., Ishizuka T., Mune T., Miura A., Ishizawa M., Kanoh Y., et al. Dehydroepiandrosterone down-regulates the expression of peroxisome proliferator-activated receptor gamma in adipocytes. Endocrinology 144 (2003) 253-259
32. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
33. Rodbell M. Metabolism of isolated fat cells: I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239 (1964) 375-380
34. Langin D., Portillo M.P., Saulnier-Blache J.S., and Lafontan M. Coexistence of three beta-adrenoceptor subtypes in white fat cells of various mammalian species. Eur J Pharmacol 199 (1991) 291-301
35. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29 (2001) e45
36. Couillard C., Gagnon J., Bergeron J., Leon A.S., Rao D.C., Skinner J.S., et al. Contribution of body fatness and adipose tissue distribution to the age variation in plasma steroid hormone concentrations in men: the HERITAGE Family Study. J Clin Endocrinol Metab 85 (2000) 1026-1031
37. De Pergola G., Giagulli V.A., Garruti G., Cospite M.R., Giorgino F., Cignarelli M., et al. Low dehydroepiandrosterone circulating levels in premenopausal obese women with very high body mass index. Metabolism 40 (1991) 187-190
38. Regelson W., Loria R., and Kalimi M. Dehydroepiandrosterone (DHEA) - the "mother steroid": I. Immunologic action. Ann N Y Acad Sci 719 (1994) 553-563
39. Salas A., Remesar X., and Esteve M. Oleoyl-estrone treatment activates apoptotic mechanisms in white adipose tissue. Life Sci 80 (2007) 293-298
40. Dieudonne M.N., Pecquery R., Leneveu M.C., and Giudicelli Y. Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor gamma2. Endocrinology 141 (2000) 649-656
41. Lemieux C., Picard F., Labrie F., Richard D., and Deshaies Y. The estrogen antagonist EM-652 and dehydroepiandrosterone prevent diet- and ovariectomy-induced obesity. Obes Res 11 (2003) 477-490
42. Lea-Currie Y.R., Wen P., and McIntosh M.K. Dehydroepiandrosterone-sulfate (DHEAS) reduces adipocyte hyperplasia associated with feeding rats a high-fat diet. Int J Obes Relat Metab Disord 21 (1997) 1058-1064
43. Ryu J.W., Kim M.S., Kim C.H., Song K.H., Park J.Y., Lee J.D., et al. DHEA administration increases brown fat uncoupling protein 1 levels in obese OLETF rats. Biochem Biophys Res Commun 303 (2003) 726-731
44. Tagliaferro A.R., Ronan A.M., Payne J., Meeker L.D., and Tse S. Increased lipolysis to beta-adrenergic stimulation after dehydroepiandrosterone treatment in rats. Am J Physiol 268 (1995) R1374-R1380
45. Kmiec Z., Pokrywka L., Kotlarz G., Kubasik J., Szutowicz A., and Mysliwski A. Effects of fasting and refeeding on serum leptin, adiponectin and free fatty acid concentrations in young and old male rats. Gerontology 51 (2005) 357-362
46. Gui Y., Silha J.V., and Murphy L.J. Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse. Obes Res 12 (2004) 1481-1491
47. Combs T.P., Berg A.H., Rajala M.W., Klebanov S., Iyengar P., Jimenez-Chillaron J.C., et al. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 52 (2003) 268-276
48. Ryan A.S., Berman D.M., Nicklas B.J., Sinha M., Gingerich R.L., Meneilly G.S., et al. Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 26 (2003) 2383-2388
49. Adamczak M., Rzepka E., Chudek J., and Wiecek A. Ageing and plasma adiponectin concentration in apparently healthy males and females. Clin Endocrinol (Oxf) 62 (2005) 114-118
50. Hernandez-Morante J.J., Milagro F., Gabaldon J.A., Martinez J.A., Zamora S., and Garaulet M. Effect of DHEA-sulfate on adiponectin gene expression in adipose tissue from different fat depots in morbidly obese humans. Eur J Endocrinol 155 (2006) 593-600
51. Karbowska J., and Kochan Z. Effect of DHEA on endocrine functions of adipose tissue, the involvement of PPAR gamma. Biochem Pharmacol 70 (2005) 249-257
52. Iwaki M., Matsuda M., Maeda N., Funahashi T., Matsuzawa Y., Makishima M., et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52 (2003) 1655-1663
53. Barnea M., Shamay A., Stark A.H., and Madar Z. A high-fat diet has a tissue-specific effect on adiponectin and related enzyme expression. Obesity (Silver Spring) 14 (2006) 2145-2153
54. Oliver P., Pico C., Serra F., and Palou A. Resistin expression in different adipose tissue depots during rat development. Mol Cell Biochem 252 (2003) 397-400
55. Kochan Z., and Karbowska J. Dehydroepiandrosterone up-regulates resistin gene expression in white adipose tissue. Mol Cell Endocrinol 218 (2004) 57-64
56. Villena J.A., Kim K.H., and Sul H.S. Pref-1 and ADSF/resistin: two secreted factors inhibiting adipose tissue development. Horm Metab Res 34 (2002) 664-670
57. Kim K.H., Lee K., Moon Y.S., and Sul H.S. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 276 (2001) 11252-11256
58. Svec F., Hilton C.W., Wright B., Browne E., and Porter J.R. The effect of DHEA given chronically to Zucker rats. Proc Soc Exp Biol Med 209 (1995) 92-97
59. Cleary M.P., Billheimer J., Finan A., Sartin J.L., and Schwartz A.G. Metabolic consequences of dehydroepiandrosterone in lean and obese adult Zucker rats. Horm Metab Res 16 Suppl 1 (1984) 43-46
60. Defronzo R.A. Glucose intolerance and aging: evidence for tissue insensitivity to insulin. Diabetes 28 (1979) 1095-1101
61. Nishimura H., Kuzuya H., Okamoto M., Yoshimasa Y., Yamada K., Ida T., et al. Change of insulin action with aging in conscious rats determined by euglycemic clamp. Am J Physiol 254 (1988) E92-E98
62. Reaven E., Wright D., Mondon C.E., Solomon R., Ho H., and Reaven G.M. Effect of age and diet on insulin secretion and insulin action in the rat. Diabetes 32 (1983) 175-180
63. Kissebah A.H. Intra-abdominal fat: is it a major factor in developing diabetes and coronary artery disease?. Diabetes Res Clin Pract 30 Suppl (1996) 25-30
64. Kissebah A.H. Insulin resistance in visceral obesity. Int J Obes 15 Suppl 2 (1991) 109-115
65. Despres J.P., Nadeau A., Tremblay A., Ferland M., Moorjani S., Lupien P.J., et al. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes 38 (1989) 304-309
66. Wolden-Hanson T., Marck B.T., Smith L., and Matsumoto A.M. Cross-sectional and longitudinal analysis of age-associated changes in body composition of male Brown Norway rats: association of serum leptin levels with peripheral adiposity. J Gerontol A Biol Sci Med Sci 54 (1999) B99-B107
67. Oliver P., Pico C., and Palou A. Ontogenesis of leptin expression in different adipose tissue depots in the rat. Pflugers Arch 442 (2001) 383-390